Signing of an exclusive Licensing Agreement with Ripple Therapeutics Corp.
Thea2021-01-18T15:00:02+01:00Théa Open Innovation signs an exclusive Licensing Agreement for the rights on Ripple Therapeutics Corporation lead product, IBE-814 for North America and Europe.